Evidence map›Paper›PMID 33788137›Full record

ArticleTargeted oncology2021

Correction to: Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.

Giorgio Patelli, Caterina Vaghi, Federica Tosi, Gianluca Mauri, Alessio Amatu, Daniela Massihnia, Silvia Ghezzi, Erica Bonazzina, Katia Bencardino, Giulio Cerea and 2 more

Open access · bronzeAbstract readPublished Erratum
In one paragraph

Article in Targeted oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Giorgio PatelliNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Caterina VaghiNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Federica TosiNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Gianluca MauriNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Alessio AmatuNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Daniela MassihniaNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Silvia GhezziNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Erica BonazzinaNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Katia BencardinoNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Giulio CereaNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Salvatore SienaNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.ORCID http://orcid.org/0000-0002-2681-2846
Andrea Sartore-BianchiNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy. andrea.sartorebianchi@unimi.it.ORCID http://orcid.org/0000-0003-0780-0409
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33788137
PMCPMC8182871
OpenAlexW3142482378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.